Evommune EVMN
NYSE EVMN
$5.19 -0.19 (-3.53%)
As of: Oct 21, 2026 · 3:41 PM EDT

Evommune (EVMN) Total Liabilities (2024 - 2026)

Updated

Evommune (EVMN) posted Total Liabilities of $24.36 million for Q2 2026, up 36.1% from the prior quarter.

Analysis

Evommune (EVMN) Total Liabilities (2024 - 2026) Analysis & Trends

At the end of FY2025, Evommune's Total Liabilities came in at $19.38 million, down 91.2% from FY2024.

  • In prior years, Evommune's Total Liabilities was $220.29 million in FY2024.
  • Quarterly Total Liabilities has run from a low of $17.9 million in Q1 2026 to a high of $267.68 million in Q3 2025 over five years.
  • According to Business Quant data, Total Liabilities for the three prior quarters was $17.9 million (Q1 2026), $19.38 million (Q4 2025) and $267.68 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Eli Lilly 1,137.42 Bn 1,106.00 Bn 19.71 Bn 108.40 Bn
2 Johnson & Johnson 617.98 Bn 536.51 Bn 17.26 Bn 116.09 Bn
3 AbbVie 502.80 Bn 475.92 Bn 12.70 Bn 141.05 Bn
4 Merck 368.67 Bn 323.05 Bn 12.21 Bn 87.82 Bn
5 Novartis Ag 298.36 Bn 262.35 Bn 11.24 Bn 80.09 Bn
6 Astrazeneca 261.17 Bn 234.85 Bn 12.86 Bn 65.46 Bn
7 Amgen 237.18 Bn 192.58 Bn 7.24 Bn 83.95 Bn
8 Gilead Sciences 191.11 Bn 165.31 Bn 6.22 Bn 37.53 Bn
9 Pfizer 169.83 Bn 116.48 Bn 10.94 Bn 115.64 Bn
10 Evommune 187.54 Mn -449.98 Mn - 24.36 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 24.36 Mn
Mar 31, 2026 17.90 Mn
Dec 31, 2025 19.38 Mn
Sep 30, 2025 267.68 Mn
Dec 31, 2024 220.29 Mn
API Access

Evommune Total Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-liabilities&ticker=EVMN&period=max&api_key=YOUR_API_KEY